The use of soluble polymers and polymer microparticles to provide improved vaccine responses after parenteral and mucosal delivery.

It is important when developing new vaccine systems to give proper attention to the question of delivery. In some cases the judicious choice of a delivery system can provide a greatly enhanced immune response and avoid the need to use a vaccine adjuvant. Delivery systems that have been developed originally for the administration of challenging drug can be… CONTINUE READING